Argentina Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

Argentina cardiovascular devices market size in 2026 is estimated at USD 717.98 million, growing from 2025 value of USD 688.52 million with 2031 projections showing USD 885.27 million, growing at 4.28% CAGR over 2026-2031. This report is Segmented by Device Type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices), by Application (Coronary Artery Disease, Arrhythmia and More), by End-User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers and More) and Geography. The Report Offers the Value (in USD Million) for all the Above Segments.

Argentina Cardiovascular Devices Market Trends and Insights

High Prevalence of Hypertensive & Diabetic Population

Argentina cardiovascular devices market growth is strongly anchored in disease burden. Registry data show 22.3% of STEMI patients arrive with heart failure, raising in-hospital mortality to 28.4% and underscoring the need for hemodynamic monitoring, implantable cardioverter defibrillators, and mechanical-circulatory support . Nationwide hypertension surveillance identifies uncontrolled blood pressure as the leading modifiable risk factor, elevating demand for ambulatory pressure monitors and wearable diagnostics . Device makers are consequently prioritizing multi-parameter implants capable of managing comorbid profiles rather than single-indication tools.

Rapid Uptake of Private Health Insurance

Elimination of premium caps allowed insurers to raise prices by up to 40% in 2024, unlocking richer benefit tiers for higher-income groups and stimulating demand for elective TAVR, atrial-fibrillation ablation, and leadless-pacemaker procedures. Hospitals in the private network now perform 3.6 elective interventions for every public-sector case, shifting OEM marketing budgets toward premium product lines. Simultaneously, public hospitals face slowing replacement cycles, pushing suppliers to introduce stripped-down versions of flagship devices.

Shortage of Electrophysiologists Outside Buenos Aires

Argentina counts fewer than 80 board-certified electrophysiologists, and 62% practice in the capital, restricting advanced rhythm-management procedures in provincial hospitals. Remote monitoring of cardiac implantable electronic devices in elderly cohorts reduced unscheduled visits by 38% in multicenter trials, underscoring tele-cardiology's role in mitigating manpower shortages. Device vendors promoting cloud-connected implants and AI-based arrhythmia triage are differentiating themselves in underserved provinces.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of Cath-Lab Infrastructure
• ANMAT Fast-Track Pathway for High-Risk Implants
• Competing Domestic Policies Favoring Low-Cost Brazilian Imports

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Diagnostics & monitoring devices accounted for 63.65% of the Argentina cardiovascular devices market size in 2025, due to their broad applicability across primary, secondary, and tertiary care. ECG, Holter, and transthoracic echo platforms remain staples; demand is reinforced by AI-enabled decision support that reduces interpretation time. Strong 4.97% CAGR through 2031 is underpinned by rising home-monitoring adoption and continuous device miniaturization. The Argentine cardiovascular devices market also benefits from hospitals adopting integrated ultrasound-angiography suites that lower referral leakage and improve throughput.

Therapeutic & surgical devices trail in volume yet punch above their weight in value, with DES, bioresorbable scaffolds, and leadless pacemakers attracting the bulk of R&D dollars. Pricing pressure intensified once the peso devaluation magnified USD-denominated import costs. Hospitals, therefore, prioritize devices with proven outcomes, such as drug-coated balloons, in small-vessel disease. Suppliers that can package implants with flexible financing and local physician-training retain an advantage in the expanding therapeutic share of the Argentina cardiovascular devices market.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • ECG Systems
    • Remote Cardiac Monitor
    • Cardiac MRI
    • Cardiac CT
    • Echocardiography / Ultrasound
    • Fractional Flow Reserve (FFR) Systems
  • Therapeutic & Surgical Devices
    • Coronary Stents
      • Drug-Eluting Stents
      • Bare-Metal Stents
      • Bioresorbable Stents
    • Catheters
      • PTCA Balloon Catheters
      • IVUS/OCT Catheters
    • Cardiac Rhythm Management
      • Pacemakers
      • Implantable Cardioverter Defibrillators
      • Cardiac Resynchronization Therapy Devices
    • Heart Valves
      • TAVR/TAVI
      • Mechanical Valves
      • Tissue/Bioprosthetic Valves
    • Ventricular Assist Devices
    • Artificial Hearts
    • Grafts & Patches
    • Other Cardiovascular Surgical Devices
• By Application
  • Coronary Artery Disease
  • Arrhythmia
  • Heart Failure
  • Structural Heart Disease
  • Hypertension
  • Others
• By End-User
  • Hospitals & Cardiac Centers
  • Home-Care Settings
  • Ambulatory Surgical Centers

List of Companies Covered in this Report:

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Edward Lifesciences
• Johnson & Johnson (Cordis / Biosense Webster)
• BIOTRONIK
• Philips (Navigator & Azurion CV Platforms)
• LivaNova
• Terumo
• MicroPort
• Meril Life Science
• Mindray
• Tecnoimagen S.A.
• Getinge
• W. L. Gore & Associates
• Cook Group
• Lepu Medical
• Sorin Group Argentina S.A.
• Electromedik S.A.
• IMPLANTEX S.R.L.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support